Annual Total Liabilities
$369.06 M
-$35.59 M-8.80%
March 31, 2024
Summary
- As of February 9, 2025, TARO annual total liabilities is $369.06 million, with the most recent change of -$35.59 million (-8.80%) on March 31, 2024.
- During the last 3 years, TARO annual total liabilities has fallen by -$342.35 million (-48.12%).
Performance
TARO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$369.06 M
-$15.02 M-3.91%
March 31, 2024
Summary
- As of February 9, 2025, TARO quarterly total liabilities is $369.06 million, with the most recent change of -$15.02 million (-3.91%) on March 31, 2024.
- Over the past year, TARO quarterly total liabilities has dropped by -$15.02 million (-3.91%).
Performance
TARO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TARO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.8% | -3.9% |
| 3 y3 years | -48.1% | -48.1% |
| 5 y5 years | +64.6% | +66.0% |
TARO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.1% | at low | -20.6% | at low |
| 5 y | 5-year | -48.1% | -39.3% | -51.1% | -39.8% |
| alltime | all time | -48.1% | -98.4% | -51.1% | -98.4% |
Taro Pharmaceutical Industries Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | $369.06 M(-8.8%) | $369.06 M(-3.9%) |
| Dec 2023 | - | $384.09 M(+3.3%) |
| Sep 2023 | - | $371.92 M(-6.2%) |
| Jun 2023 | - | $396.52 M(-2.0%) |
| Mar 2023 | $404.65 M(-13.0%) | $404.65 M(+0.9%) |
| Sep 2022 | - | $401.00 M(-1.3%) |
| Jun 2022 | - | $406.28 M(-12.6%) |
| Mar 2022 | $464.92 M(-34.6%) | $464.92 M(+9.0%) |
| Dec 2021 | - | $426.46 M(-33.8%) |
| Sep 2021 | - | $644.05 M(-14.7%) |
| Jun 2021 | - | $755.25 M(+6.2%) |
| Mar 2021 | $711.42 M(+207.3%) | $711.42 M(+14.5%) |
| Dec 2020 | - | $621.25 M(-1.0%) |
| Sep 2020 | - | $627.36 M(-11.1%) |
| Jun 2020 | - | $705.55 M(+204.8%) |
| Mar 2020 | $231.49 M(+3.3%) | $231.49 M(+4.1%) |
| Dec 2019 | - | $222.36 M(+1.8%) |
| Sep 2019 | - | $218.40 M(+10.7%) |
| Jun 2019 | - | $197.35 M(-12.0%) |
| Mar 2019 | $224.20 M(+0.6%) | $224.20 M(+0.1%) |
| Dec 2018 | - | $224.00 M(+7.8%) |
| Sep 2018 | - | $207.72 M(+5.0%) |
| Jun 2018 | - | $197.82 M(-11.2%) |
| Mar 2018 | $222.81 M(+3.2%) | $222.81 M(+2.0%) |
| Dec 2017 | - | $218.41 M(+5.9%) |
| Sep 2017 | - | $206.32 M(-2.6%) |
| Jun 2017 | - | $211.76 M(-1.9%) |
| Mar 2017 | $215.95 M(-13.9%) | $215.95 M(-11.8%) |
| Dec 2016 | - | $244.92 M(+6.0%) |
| Sep 2016 | - | $231.15 M(-7.1%) |
| Jun 2016 | - | $248.90 M(-0.8%) |
| Mar 2016 | $250.89 M(-21.7%) | $250.89 M(-15.0%) |
| Dec 2015 | - | $295.01 M(+3.3%) |
| Sep 2015 | - | $285.62 M(+10.3%) |
| Jun 2015 | - | $259.00 M(-19.2%) |
| Mar 2015 | $320.36 M(+21.4%) | $320.36 M(+15.8%) |
| Dec 2014 | - | $276.59 M(+12.9%) |
| Sep 2014 | - | $244.99 M(-6.1%) |
| Jun 2014 | - | $260.83 M(-1.1%) |
| Mar 2014 | $263.78 M(+22.3%) | $263.78 M(+3.4%) |
| Dec 2013 | - | $255.16 M(+2.1%) |
| Sep 2013 | - | $249.90 M(+6.7%) |
| Jun 2013 | - | $234.30 M(+8.6%) |
| Mar 2013 | $215.68 M(-7.6%) | $215.68 M(+9.4%) |
| Dec 2012 | - | $197.20 M(-3.9%) |
| Sep 2012 | - | $205.20 M(+7.3%) |
| Jun 2012 | - | $191.30 M(-18.1%) |
| Mar 2012 | $233.47 M(+3.9%) | $233.47 M(+3.9%) |
| Dec 2011 | $224.78 M(+30.7%) | $224.78 M(+6.6%) |
| Sep 2011 | - | $210.96 M(+19.0%) |
| Jun 2011 | - | $177.27 M(+0.1%) |
| Mar 2011 | - | $177.02 M(+3.0%) |
| Dec 2010 | $171.93 M(-38.6%) | $171.93 M(-30.6%) |
| Sep 2010 | - | $247.70 M(-6.2%) |
| Jun 2010 | - | $264.16 M(-5.7%) |
| Dec 2009 | $280.19 M | $280.19 M(-5.4%) |
| Sep 2009 | - | $296.03 M(+10.9%) |
| Jun 2009 | - | $266.87 M(-0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | $268.53 M(-13.1%) |
| Dec 2008 | $308.88 M(-6.4%) | $308.88 M(+2.6%) |
| Sep 2008 | - | $301.16 M(-28.3%) |
| Dec 2007 | $330.12 M(-11.9%) | - |
| Dec 2006 | $374.91 M(-10.8%) | - |
| Dec 2005 | $420.15 M(+28.1%) | $420.15 M(+29.1%) |
| Sep 2005 | - | $325.42 M(+0.4%) |
| Jun 2005 | - | $324.14 M(+1.8%) |
| Mar 2005 | - | $318.44 M(-2.9%) |
| Dec 2004 | $328.03 M(+22.7%) | $328.03 M(+8.7%) |
| Sep 2004 | - | $301.69 M(+6.1%) |
| Jun 2004 | - | $284.28 M(+1.3%) |
| Mar 2004 | - | $280.77 M(+5.0%) |
| Dec 2003 | $267.41 M(+144.1%) | $267.41 M(+30.3%) |
| Sep 2003 | - | $205.23 M(+7.0%) |
| Jun 2003 | - | $191.79 M(+35.1%) |
| Mar 2003 | - | $141.94 M(+29.6%) |
| Dec 2002 | $109.55 M(+23.6%) | $109.55 M(+14.2%) |
| Sep 2002 | - | $95.94 M(-1.6%) |
| Jun 2002 | - | $97.54 M(+11.5%) |
| Mar 2002 | - | $87.49 M(-1.3%) |
| Dec 2001 | $88.62 M(+26.5%) | $88.62 M(+3.7%) |
| Sep 2001 | - | $85.42 M(+4.6%) |
| Jun 2001 | - | $81.69 M(+14.5%) |
| Mar 2001 | - | $71.32 M(+1.8%) |
| Dec 2000 | $70.06 M(+39.4%) | $70.06 M(+2.0%) |
| Sep 2000 | - | $68.70 M(+23.7%) |
| Jun 2000 | - | $55.53 M(+3.3%) |
| Mar 2000 | - | $53.74 M(+6.9%) |
| Dec 1999 | $50.26 M(+10.1%) | $50.26 M(-10.9%) |
| Sep 1999 | - | $56.40 M(+5.6%) |
| Jun 1999 | - | $53.40 M(+17.1%) |
| Mar 1999 | - | $45.60 M(-0.1%) |
| Dec 1998 | $45.67 M(+3.1%) | $45.67 M(-8.3%) |
| Mar 1998 | - | $49.80 M(+12.4%) |
| Dec 1997 | $44.30 M(+24.8%) | $44.30 M(+3.0%) |
| Sep 1997 | - | $43.00 M(+8.9%) |
| Jun 1997 | - | $39.50 M(+5.6%) |
| Mar 1997 | - | $37.40 M(+5.4%) |
| Dec 1996 | $35.50 M(+39.8%) | $35.50 M(+9.9%) |
| Sep 1996 | - | $32.30 M(+1.3%) |
| Jun 1996 | - | $31.90 M(+13.9%) |
| Mar 1996 | - | $28.00 M(+10.2%) |
| Dec 1995 | $25.40 M(+21.5%) | $25.40 M(+21.5%) |
| Dec 1994 | $20.90 M(+29.0%) | $20.90 M(+29.0%) |
| Dec 1993 | $16.20 M(+7.3%) | $16.20 M(+7.3%) |
| Dec 1992 | $15.10 M(+60.6%) | $15.10 M(+37.3%) |
| Sep 1992 | - | $11.00 M(+22.2%) |
| Jun 1992 | - | $9.00 M(+16.9%) |
| Mar 1992 | - | $7.70 M(-18.1%) |
| Dec 1991 | $9.40 M(+1.1%) | $9.40 M(+11.9%) |
| Sep 1991 | - | $8.40 M(+3.7%) |
| Jun 1991 | - | $8.10 M(-4.7%) |
| Mar 1991 | - | $8.50 M(-8.6%) |
| Dec 1990 | $9.30 M(+24.0%) | $9.30 M(+38.8%) |
| Mar 1990 | - | $6.70 M(-10.7%) |
| Dec 1989 | $7.50 M(+17.2%) | $7.50 M(+17.2%) |
| Dec 1988 | $6.40 M(+10.3%) | $6.40 M(+10.3%) |
| Dec 1987 | $5.80 M | $5.80 M |
FAQ
- What is Taro Pharmaceutical Industries annual total liabilities?
- What is the all time high annual total liabilities for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual total liabilities year-on-year change?
- What is Taro Pharmaceutical Industries quarterly total liabilities?
- What is the all time high quarterly total liabilities for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly total liabilities year-on-year change?
What is Taro Pharmaceutical Industries annual total liabilities?
The current annual total liabilities of TARO is $369.06 M
What is the all time high annual total liabilities for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual total liabilities is $711.42 M
What is Taro Pharmaceutical Industries annual total liabilities year-on-year change?
Over the past year, TARO annual total liabilities has changed by -$35.59 M (-8.80%)
What is Taro Pharmaceutical Industries quarterly total liabilities?
The current quarterly total liabilities of TARO is $369.06 M
What is the all time high quarterly total liabilities for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly total liabilities is $755.25 M
What is Taro Pharmaceutical Industries quarterly total liabilities year-on-year change?
Over the past year, TARO quarterly total liabilities has changed by -$15.02 M (-3.91%)